Prevention of Common Cancers of the Female Genital Tract
The world has seen incremental success in the outcomes of patients with cancer over the past 60 years. Ever-growing surgical expertise, improvements in radiation techniques, combination chemotherapy, supportive care, improved diagnostics, and more recently targeted therapy, all have led to a changed landscape. A significant number of cancer patients, previously deemed incurable are now cured. What cannot be cured does not have to be endured. Several incurable cancers are now managed like chronic disease. However, despite the success in treatment of cancer, total number of patients who die as a result of cancer continue to increase, and this is a direct reflection of the rising incidence. According to the Globocan, 12.7 million patients were diagnosed with cancer in 2008, and the number is likely to increase almost twofold to 22.2 million by 2030. Similarly, 7.6 million people died of cancer in 2008, and the number is likely to increase to 17 million by 2030. Despite all the excitement and success in accurate diagnosis and refined treatment of cancer, clearly a lot more needs to be achieved in research and implementation of effective policies to reduce the incidence of cancer, in order to decrease the overall burden of the disease and the attendant mortality. Cancer should be treated across the continuum, if meaningful gain in survival is the goal. In this chapter, developments in the field of prevention of gynecological cancers are reviewed.
- 1.Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. GLOBOCAN 2012 v1.1, cancer incidence and mortality worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2014. Available from: http://globocan.iarc.fr. Accessed 16 January 2015.Google Scholar
- 2.Romaguera D, Vergnaud AC, Peeters PH, van Gils CH, Chan DS, Ferrari P, et al. Is concordance with World Cancer Research Fund/American Institute for Cancer Research guidelines for cancer prevention related to subsequent risk of cancer? Results from the EPIC study. Am J Clin Nutr. 2012;96:150–63.CrossRefPubMedGoogle Scholar
- 3.Vergnaud AC, Romaguera D, Peeters PH, van Gils CH, Chan DS, Romieu I, et al. Adherence to the World Cancer Research Fund/American Institute for Cancer Research guidelines and risk of death in Europe: results from the European Prospective Investigation into Nutrition and Cancer cohort study1,4. Am J Clin Nutr. 2013;97:1107–20.CrossRefPubMedGoogle Scholar
- 8.Toss C, Tomasello E, Razzaboni G, et al. Hereditary ovarian cancer: not only BRCA 1 and 2 genes. BioMed Res Int. 2015:341–8.Google Scholar
- 14.Thomson CA, Crane TE, Miller A, et al. A randomized trial of diet and physical activity in women treated for stage II–IV ovarian cancer: rationale and design of the Lifestyle Intervention for Ovarian Cancer Enhanced Survival (LIVES): an NRG Oncology/Gynecologic Oncology Group (GOG-225) Study. Contemp Clin Trials. 2016;49:181–9.CrossRefPubMedPubMedCentralGoogle Scholar
- 17.Moyer VA, U.S. Preventive Services Task Force. Screening for ovarian cancer: U.S. Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med. 2012;157(12):900–4. https://doi.org/10.7326/0003-4819-157-11-201212040-00539.CrossRefPubMedGoogle Scholar
- 20.Paluch-Shimon S, Cardoso F, Sessa C, et al. on behalf of the ESMO Guidelines Committee. Prevention and screening in BRCA mutation carriers and other breast/ovarian hereditary cancer syndromes: ESMO Clinical Practice Guidelines for cancer prevention and screening Ann of Oncol 27 (Suppl 5): v103–v110, 2016 doi: https://doi.org/10.1093/annonc/mdw327.
- 23.Colombo N, Creutzberg C, Amant F, et al. ESMO-ESGO-ESTRO Endometrial Consensus Conference Working Group. ESMO-ESGO-ESTRO consensus conference on endometrial cancer: diagnosis, treatment and follow-up. Radiother Oncol. 2015;117(3):559–81. https://doi.org/10.1016/j.radonc.2015.11.013.CrossRefPubMedGoogle Scholar
- 35.Arrossi S, Temin S, Garland S, et al. Primary prevention of cervical cancer. ASCO. First Global Guidance for HPV Vaccination for Cervical Cancer Prevention. ASCO’s website. Mar. 17, 2017. doi: https://doi.org/10.1200/JGO.2016.008151.